HomeNewsBusinessUncertainty around revival plans pushes Jet Airways employees to explore alternative avenues

Uncertainty around revival plans pushes Jet Airways employees to explore alternative avenues

The Jalan-Kalrock consortium, the new owner, has said that while it awaits the handover of Jet Airways under the revival process, the longer-than-expected time taken for its completion may result in some difficult decisions having to be made.

December 06, 2022 / 16:50 IST
Story continues below Advertisement
Jet Airways crew photographed after operating proving flights. (Image credit: jetairways/Twitter)
Jet Airways crew photographed after operating proving flights. (Image credit: jetairways/Twitter)

After Jet Airways’s revival plans hit another roadblock in November, its employees are once again left questioning their future.

Last month, Jet Airways temporarily docked the salaries of some of its staff by up to 50 percent and sent some more on leave without pay.

Story continues below Advertisement

Jet Airways chief executive officer Sanjiv Kapoor had in November in an interview with Moneycontrol said that he was confident Jet Airways will have a solid team of industry professionals when it is ready to relaunch operations.

Passionate and proud 

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show